Compare RYZ & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYZ | QDEL |
|---|---|---|
| Founded | 1842 | 1979 |
| Country | United States | United States |
| Employees | 4300 | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2014 | 2022 |
| Metric | RYZ | QDEL |
|---|---|---|
| Price | $24.78 | $10.76 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 326.9K | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.82% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $75.79 | $3.51 |
| Revenue Next Year | $2.17 | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.34 | $9.92 |
| 52 Week High | $29.03 | $35.58 |
| Indicator | RYZ | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.45 | 39.34 |
| Support Level | $23.77 | $10.39 |
| Resistance Level | $29.03 | $12.85 |
| Average True Range (ATR) | 1.44 | 0.92 |
| MACD | -0.32 | 0.15 |
| Stochastic Oscillator | 18.47 | 27.30 |
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company has one operating and reportable segment, metals service centers. It derives substantially all of its sales from the processing and distribution of met. Geographically, the majority revenue is generated from the United States.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.